My NCBI | Sign In
RSS Settings
  • Search: cancer AND gene AND (ELE1[TI] OR ARA70[TI] OR PTC3[TI])

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 33

    1.

    High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells.

    Fiore AP, Fuziwara CS, Kimura ET.

    Thyroid. 2009 Nov;19(11):1249-56.PMID: 19725779 [PubMed - in process]Related articles

    2.

    Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.

    Jin L, Burniat A, Dumont JE, Miot F, Corvilain B, Franc B.

    Br J Cancer. 2008 Dec 2;99(11):1874-83. Epub 2008 Nov 4. Erratum in: Br J Cancer. 2009 Mar 24;100(6):1013. PMID: 18985036 [PubMed - indexed for MEDLINE]Related articles

    3.

    Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.

    Burniat A, Jin L, Detours V, Driessens N, Goffard JC, Santoro M, Rothstein J, Dumont JE, Miot F, Corvilain B.

    Endocrinology. 2008 Oct;149(10):5107-17. Epub 2008 Jun 26.PMID: 18583418 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70.

    Peng Y, Li CX, Chen F, Wang Z, Ligr M, Melamed J, Wei J, Gerald W, Pagano M, Garabedian MJ, Lee P.

    Am J Pathol. 2008 Jan;172(1):225-35. Epub 2007 Dec 21.PMID: 18156210 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.

    Mesa C Jr, Mirza M, Mitsutake N, Sartor M, Medvedovic M, Tomlinson C, Knauf JA, Weber GF, Fagin JA.

    Cancer Res. 2006 Jul 1;66(13):6521-9.PMID: 16818623 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene.

    Iavarone C, Acunzo M, Carlomagno F, Catania A, Melillo RM, Carlomagno SM, Santoro M, Chiariello M.

    J Biol Chem. 2006 Apr 14;281(15):10567-76. Epub 2006 Feb 16.PMID: 16484222 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration.

    Elisei R, Romei C, Castagna MG, Lisi S, Vivaldi A, Faviana P, Marinò M, Ceccarelli C, Pacini F, Pinchera A.

    Thyroid. 2005 Dec;15(12):1355-61.PMID: 16405408 [PubMed - indexed for MEDLINE]Related articles

    8.

    RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).

    Nakazawa T, Kondo T, Kobayashi Y, Takamura N, Murata S, Kameyama K, Muramatsu A, Ito K, Kobayashi M, Katoh R.

    Cancer. 2005 Sep 1;104(5):943-51.PMID: 16015630 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.

    Liu RT, Chou FF, Wang CH, Lin CL, Chao FP, Chung JC, Huang CC, Wang PW, Cheng JT.

    Thyroid. 2005 Apr;15(4):326-35.PMID: 15876154 [PubMed - indexed for MEDLINE]Related articles

    10.

    ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients.

    Di Cristofaro J, Vasko V, Savchenko V, Cherenko S, Larin A, Ringel MD, Saji M, Marcy M, Henry JF, Carayon P, De Micco C.

    Endocr Relat Cancer. 2005 Mar;12(1):173-83.PMID: 15788648 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Endogenous coactivator ARA70 interacts with estrogen receptor alpha (ERalpha) and modulates the functional ERalpha/androgen receptor interplay in MCF-7 cells.

    Lanzino M, De Amicis F, McPhaul MJ, Marsico S, Panno ML, Andò S.

    J Biol Chem. 2005 May 27;280(21):20421-30. Epub 2005 Mar 15.PMID: 15772083 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.

    Rhoden KJ, Johnson C, Brandao G, Howe JG, Smith BR, Tallini G.

    Lab Invest. 2004 Dec;84(12):1557-70.PMID: 15502856 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells.

    Shinohara S, Rothstein JL.

    Oncogene. 2004 Sep 30;23(45):7571-9.PMID: 15326486 [PubMed - indexed for MEDLINE]Related articles

    14.

    Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.

    Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C.

    J Biol Chem. 2004 Aug 6;279(32):33438-46. Epub 2004 May 27.PMID: 15166229 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Induction and repression of peroxisome proliferator-activated receptor alpha transcription by coregulator ARA70.

    Heinlein CA, Chang C.

    Endocrine. 2003 Jul;21(2):139-46.PMID: 12897377 [PubMed - indexed for MEDLINE]Related articles

    16.

    Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells.

    Rahman MM, Miyamoto H, Takatera H, Yeh S, Altuwaijri S, Chang C.

    J Biol Chem. 2003 May 30;278(22):19619-26. Epub 2003 Mar 20.PMID: 12649293 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.

    Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M.

    Am J Pathol. 2002 Jan;160(1):247-54.PMID: 11786418 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers.

    Kollara A, Kahn HJ, Marks A, Brown TJ.

    Breast Cancer Res Treat. 2001 Jun;67(3):245-53.PMID: 11561770 [PubMed - indexed for MEDLINE]Related articles

    19.

    RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.

    Klugbauer S, Pfeiffer P, Gassenhuber H, Beimfohr C, Rabes HM.

    Genomics. 2001 Apr 15;73(2):149-60.PMID: 11318605 [PubMed - indexed for MEDLINE]Related articles

    20.

    The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane.

    Monaco C, Visconti R, Barone MV, Pierantoni GM, Berlingieri MT, De Lorenzo C, Mineo A, Vecchio G, Fusco A, Santoro M.

    Oncogene. 2001 Feb 1;20(5):599-608.PMID: 11313992 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    2 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity